Advertisement
Canada markets closed

  • S&P/TSX

    21,642.87
    -97.33 (-0.45%)
     

  • S&P 500

    5,051.41
    -10.41 (-0.21%)
     

  • DOW

    37,798.97
    +63.86 (+0.17%)
     

  • CAD/USD

    0.7234
    -0.0019 (-0.27%)
     

  • CRUDE OIL

    85.35
    -0.01 (-0.01%)
     

  • Bitcoin CAD

    88,267.42
    +1,042.10 (+1.19%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,399.80
    -8.00 (-0.33%)
     

  • RUSSELL 2000

    1,967.48
    -8.23 (-0.42%)
     

  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     

  • NASDAQ futures

    17,912.50
    +31.25 (+0.17%)
     

  • VOLATILITY

    18.40
    -0.83 (-4.32%)
     

  • FTSE

    7,820.36
    -145.17 (-1.82%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6812
    -0.0012 (-0.18%)
     
BREAKING:

$535B CANADA BUDGET PROJECTS $39.8B DEFICIT, AIMS TO RESTORE ECONOMIC FAIRNESS

It seeks to ease the housing and affordability crisis by making older, wealthier Canadians pay more

Today’s Research Reports on Aurinia Pharmaceuticals, Revive Therapeutics, Canopy Growth and Spectral Medical

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 15, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

Revive Therapeutics Ltd.
https://rdinvesting.com/news/?ticker=RVV.V

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO

Spectral Medical Inc.
https://rdinvesting.com/news/?ticker=EDT.TO

ADVERTISEMENT

Aurinia Pharmaceuticals' stock edged 0.14% higher Wednesday, to close the day at $6.94. The stock recorded a trading volume of 29,990 shares, which was below its three months average volume of 51,423 shares. In the last year, Aurinia Pharmaceuticals' shares have traded in a range of 5.68 - 13.04. The share price has gained 22.18% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.78 is below its 200-day moving average of $7.07. Shares of Aurinia Pharmaceuticals have gained approximately 21.33 percent year-to-date.

Access RDI’s Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

On Wednesday, shares of Revive Therapeutics recorded a trading volume of 36,000 shares, which was below the three months average volume of 783,038 shares. The stock ended the day 11.32% lower at 0.23. The share price has gained 80.77% from its 52 week low with a 52 week trading range of 0.13 - 0.51. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.28 is greater than its 200-day moving average of $0.25. Shares of Revive Therapeutics have fallen approximately 43.37 percent year-to-date.

Access RDI’s Revive Therapeutics Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=RVV.V

Canopy Growth's stock moved 2.63% lower Wednesday, to close the day at $31.10. The stock recorded a trading volume of 2,841,001 shares, which was below its three months average volume of 7,281,466 shares. In the last year, Canopy Growth's shares have traded in a range of 6.58 - 44.00. The share price has gained 372.64% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $29.55 is greater than its 200-day moving average of $21.39. Shares of Canopy Growth have gained approximately 4.57 percent year-to-date.

Access RDI’s Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO

On Wednesday, shares of Spectral Medical recorded a trading volume of 12,905 shares, which was below the three months average volume of 74,818 shares. The stock ended the day flat at 0.40. The share price has gained 37.93% from its 52 week low with a 52 week trading range of 0.29 - 0.64. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.39 is greater than its 200-day moving average of $0.38. Shares of Spectral Medical have gained approximately 5.26 percent year-to-date.

Access RDI’s Spectral Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EDT.TO

Our Actionable Research on Aurinia Pharmaceuticals Inc. (TSX:AUP.TO), Revive Therapeutics Ltd. (TSXV:RVV.V), Canopy Growth Corporation (TSX:WEED.TO) and Spectral Medical Inc. (TSX:EDT.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com